KALA BIO, INC. Operating Lease Liability
KALA BIO, INC. (KALA) had Operating Lease Liability of $1.53 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-11-19
- 2025-09-30: Operating Lease, Liability $1.53M.
- 2025-06-30: Operating Lease, Liability $1.63M.
- 2025-03-31: Operating Lease, Liability $1.73M.
- 2024-12-31: Operating Lease, Liability $1.81M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-09-30 | $1.53M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $1.63M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.73M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.81M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.98M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.06M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.13M 10-K · filed 2024-03-29 |
| 2023-09-30 | $2.20M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-04 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-04 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2019-09-30 | $30.19M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $30.86M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $31.08M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |